United Kingdom: Life Sciences, Biotechnology & Nanotechnology

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

European Biosimilar Updates – Alvotech/Advanz's MYNZEPLI Approval And Bio-Thera/STADA Tocilizumab Alliance

On August 21, 2025, Alvotech and Advanz Pharma Holdco Limited ("Advanz") announced that MYNZEPLI®, a biosimilar of Regeneron's EYLEA® (aflibercept), was approved by the European Commission.

European Union Healthcare

GP

Goodwin Procter LLP

Hot Topics: Life Sciences

Topics in this month's update include: a decline in the number of "megatenants" in the US life sciences sector; the MHRA being designated as a WHO-Listed Authority; and a surge in Chinese biotech share values.

United Kingdom Healthcare

AG

Addleshaw Goddard

Neurotech Patents In Europe: Methods, Medical Devices, And The EPC Exclusion

The field of neurotechnology is rapidly evolving, bringing together advances in neuroscience, engineering, materials science, and computing. These innovations hold the potential to transform...

United Kingdom IP

MC

Marks & Clerk

The Thursday Investment Club: The Case For Later Living

With the UK's ageing population projected to increase, the market for later living homes continues to evolve and, with its potential for growth, investment interest in the sector can be expected to continue to gain momentum in the years ahead.

United Kingdom Healthcare

KL

Herbert Smith Freehills Kramer LLP

Tackling Tech Debt, Unlocking Value In Healthcare Portfolio Companies

United Kingdom Healthcare

A

AlixPartners

Court Of Appeal Deals With Price-less Contract

United Kingdom Litigation

LS

Lewis Silkin

Leading The Way In Life Sciences IP: Q&A With Laura Kehoe

United Kingdom IP

KL

Keltie LLP

Early Access Service To Launch For Innovative Medical Devices

United Kingdom Healthcare

BJ

Browne Jacobson

UK Court Of Appeal Upholds Moderna MRNA Patent Against Pfizer/BioNTech

United Kingdom IP

GP

Goodwin Procter LLP

Launch Of The Biotech And Biomanufacturing Hub

United Kingdom IP

B

Boult Wade Tennant

Covert Medication – What You Need To Know (8 August 2025)

United Kingdom Healthcare

DL

Duncan Lewis & Co Solicitors

UK Medical Devices Regulations: Further Changes Afoot

United Kingdom Healthcare

AP

Arnold & Porter

UK Proposes Early Access Service For Innovative Medical Devices

United Kingdom Healthcare

AP

Arnold & Porter

EU Regulatory Reform For Medicinal Products: Bolar Exemption

United Kingdom Healthcare

KL

Herbert Smith Freehills Kramer LLP

Failure To Prevent Fraud: What The New Legislation Means For Your Organisation

United Kingdom Criminal

CK

Carson Kaye

HR Briefing: Competition And Employment (Podcast)

United Kingdom Anti-trust

M

Macfarlanes LLP

Tech 10 – Episode 6: The Power Of Platforms (Video)

United Kingdom Technology

A

AlixPartners

HR Briefing - July 2025

United Kingdom Employment

M

Macfarlanes LLP

When Boundaries Are Crossed: Neighbour Disputes – A Legal Perspective (Podcast)

United Kingdom Litigation

GC

Gatehouse Chambers

Watch What The Federal Government Does, Not What It Says, About Artificial Intelligence

Since the Trump Administration's start, its speak has been all about "removing the barriers to American leadership in artificial intelligence."

United Kingdom Technology

IG

IR Global

Product Regulation And Metrology Bill Receives Royal Assent

The Product Regulation and Metrology Act 2025 reforms the UK's post-Brexit product safety, metrology, and consumer protection frameworks.

United Kingdom Healthcare

JD

Jones Day

Hot Topics: Life Sciences

This update focuses on: the European Commission's new strategy for life sciences; the latest on tariffs on pharmaceutical imports; Microsoft introduces it's new AI diagnostic tool...

United Kingdom Healthcare

AG

Addleshaw Goddard

Virtual And Digital Health Digest – July 2025

This digest covers key virtual and digital health regulatory and public policy developments during June and early July 2025 from the United Kingdom and European Union.

United Kingdom Healthcare

AP

Arnold & Porter

Supporting Growth: The UK's Plan To Unlock The Potential Of Life Sciences

United Kingdom Healthcare

GW

Gowling WLG

The UK Government Has Plans: What Does This Mean For The Life Sciences Sector?

United Kingdom Healthcare

AP

Arnold & Porter

Life Science Sector Plans Issued

United Kingdom Healthcare

LS

Lewis Silkin

A New European Strategy To Foster Life Sciences Innovation And Market Access

European Union Healthcare

AO

A&O Shearman

Tackling The Source Of Phantom Limb Pain With Nerve Stimulation

United Kingdom IP

MC

Marks & Clerk

The Case For Core Focus Among Mid-market Medical Device Companies

United Kingdom Healthcare

A

AlixPartners

Neurotech Patents In Europe: Part 2 - Novelty, Inventive Step, And Device-Specific Pitfalls

United Kingdom IP

MC

Marks & Clerk

Creative Deal Structures Help Life Sciences Innovators Ride Out The Macro Storm

United Kingdom Commercial

AO

A&O Shearman

UK Government Issues Tech And Digital Sector Plan

United Kingdom Technology

LS

Lewis Silkin

The Cali Fund And DSI: What Life Sciences And Biotech Companies Need To Know Now

Worldwide Healthcare

PC

Potter Clarkson

Neurotech Patents In Europe: Part 2 - Novelty, Inventive Step, And Device-Specific Pitfalls

Building on my previous article relating neurotech to European patentability exclusions, I will discuss how the novelty of medical devices is assessed differently from pharmaceuticals.

United Kingdom IP

MC

Marks & Clerk

Creative Deal Structures Help Life Sciences Innovators Ride Out The Macro Storm

Globally, market volatility has eroded confidence and subdued M&A activity. A "wait and see" approach is the prevailing sentiment for many market participants...

United Kingdom Commercial

AO

A&O Shearman

UK Government Issues Tech And Digital Sector Plan

In the latest of our articles about the UK government's industrial strategy and sector plans, we're now taking a look at its tech and digital sector plan.

United Kingdom Technology

LS

Lewis Silkin

The Cali Fund And DSI: What Life Sciences And Biotech Companies Need To Know Now

The launch of the Cali Fund at COP16 marked a new international framework for sharing benefits from Digital Sequence Information (DSI).

Worldwide Healthcare

PC

Potter Clarkson

The Pioneers: Financial Times Interview With Michelle Mitchell

United Kingdom Healthcare

WL

Withers LLP

UPC Delivers First Judgment On Validity And Infringement Of A Second Medical Use Claim

The Dusseldorf Local Division (LD) has delivered the UPC's first Judgment on second medical use claims. The case concerns EP 3 536 712, exclusively licensed to Sanofi by Regeneron.

United Kingdom IP

HL

HGF Ltd

Looking To The Future - UK Biotech In 2035

The bioindustry association (BIA) have issued a new report setting out their vision for UK biotech in 2035. The headline approach is that there needs to be a "shift in mindset" to unlock the UK's full potential.

United Kingdom Healthcare

MC

Marks & Clerk

The EU Biotech Act Has Been Delayed — Here's What That Means

The current EU regulatory landscape for biotechnology is widely viewed as insufficient to be able to exploit the full potential of such technologies.

European Union Healthcare

AP

Arnold & Porter

£13.9bn Of R&D Funding

The UK government has announced a record-breaking £13.9 billion in research and development (R&D) funding for the coming year.

United Kingdom Strategy

IG

IR Global

The Effect Of The Unified Patent Court (UPC) On Opposition Proceedings At The European Patent Office (EPO)

United Kingdom IP

KL

Keltie LLP

Global Insights: Patent Protection For Polymorphs

B

Boult Wade Tennant

Recent Updates On Reform Of UK Clinical Trial Landscape

United Kingdom Healthcare

AP

Arnold & Porter

Blueprints For Growth: Perspectives On Life Sciences & Innovation Investments

United Kingdom Real Estate

AG

Addleshaw Goddard

Future R&D Funding In The UK

United Kingdom Healthcare

MC

Marks & Clerk

Going Down The Bio-Produced Silk Road

United Kingdom IP

MC

Marks & Clerk

A New Approach To Regulation By The MHRA And NICE

United Kingdom Healthcare

AO

A&O Shearman

ABPI Calls For Changes To "Unsustainable" Medicines Pricing Scheme

United Kingdom Healthcare

AP

Arnold & Porter

Is Seaweed The New Wonder Product?

United Kingdom Healthcare

MC

Marks & Clerk

Will Labour's Policy Prescription Create A Stronger UK Life Sciences Sector?

United Kingdom Healthcare

AO

A&O Shearman

What To Know When Selling Your Pharmacy

United Kingdom Healthcare

RF

Ronald Fletcher Baker

EU Leads Global Charge As Abuse Of Dominance Cases Target Big Tech

Worldwide Anti-trust

AO

A&O Shearman

A Culture And Environment For Neurodiverse Teams

United Kingdom IP

MC

Marks & Clerk

Pharma TM Articles

United Kingdom Healthcare

R

Rouse

Can You Turn A Skin Cell Into Another Type Of Cell?

United Kingdom IP

MC

Marks & Clerk

See more

Latest Videos

See more

Legally Vocal: Patrick Duxbury On His COVID-19 Vaccine Work And 20-Year Career In Life Sciences (Video)

GW

Gowling WLG

EU And UK Compliance Considerations In Remote Promotion Training And Medical Information Services (Video)

AP

Arnold & Porter

Claim One – #01 EPO Oral Proceedings (Video)

H

HLK

The International Advantage Of Using A UK Patent Attorney - Dehns And ConceptoMed

D

Dehns

Measuring The Return From Pharmaceutical Innovation 2012 (Video Content)

D

Deloitte

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More